Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy
- Author
- DOERHOLT, Katja1 ; DUONG, Trinh2 ; GIBB, Diana M; TOOKEY, Pat3 ; BUTLER, Karina4 ; LYALL, Hermione5 ; SHARLAND, Mike6 ; NOVELLI, Vas7 ; RIORDAN, Andrew8 ; DUNN, David2 ; SARAH WALKER, A2
[1] St. Peter's Hospital, Chertsey, United Kingdom
[2] MRC Clinical Trials Unit, United Kingdom
[3] Institute of Child Health, London, United Kingdom
[4] Our Lady's Hospital for Sick Children, Dublin, Ireland
[5] St. Mary's Hospital, United Kingdom
[6] St. George's Hospital, United Kingdom
[7] Great Ormond Street Hospital, London, United Kingdom
[8] Royal Liverpool Children's Hospital, Liverpool, United Kingdom
Collaborative HIV Paediatric Study (CHIPS) - Source
The Pediatric infectious disease journal. 2006, Vol 25, Num 5, pp 420-426, 7 p ; ref : 33 ref
- CODEN
- PIDJEV
- ISSN
- 0891-3668
- Scientific domain
- Microbiology, infectious diseases; Pediatrics
- Publisher
- Lippincott, Baltimore, MD
/
Lippincott, Hagerstown, MD
/
Lippincott, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HIV antiretroviral therapy disease progression infants mortality
- Keyword (fr)
- Antiviral Chimiothérapie Evolution Mortalité Nourrisson Pronostic Pédiatrie SIDA Traitement Virus HIV1 Irlande Royaume Uni Homme Immunodéficit Immunopathologie Infection Lentivirus Retroviridae Virose Virus immunodéficience humaine Virus Europe
- Keyword (en)
- Antiviral Chemotherapy Evolution Mortality Infant Prognosis Pediatrics AIDS Treatment HIV-1 virus Ireland United Kingdom Human Immune deficiency Immunopathology Infection Lentivirus Retroviridae Viral disease Human immunodeficiency virus Virus Europe
- Keyword (es)
- Antiviral Quimioterapia Evolución Mortalidad Lactante Pronóstico Pediatría SIDA Tratamiento HIV-1 virus Irlanda Reino Unido Hombre Inmunodeficiencia Inmunopatología Infección Lentivirus Retroviridae Virosis Human immunodeficiency virus Virus Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies
- Discipline
- Immunopathology Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17772297
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/01.inf.0000214994.44346.d3 
https://dx.doi.org/10.1097/01.inf.0000214994.44346.d3
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.inf.0000214994.44346.d3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The Pediatric infectious disease journal\";s:9:\"\u0000*\u0000stitle\";s:23:\"Pediatr. infect. dis. j\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"426\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0891-3668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"DOERHOLT\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Katja\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"DUONG, Trinh\";i:1;s:13:\"GIBB, Diana M\";i:2;s:11:\"TOOKEY, Pat\";i:3;s:14:\"BUTLER, Karina\";i:4;s:15:\"LYALL, Hermione\";i:5;s:14:\"SHARLAND, Mike\";i:6;s:12:\"NOVELLI, Vas\";i:7;s:15:\"RIORDAN, Andrew\";i:8;s:11:\"DUNN, David\";i:9;s:15:\"SARAH WALKER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PIDJEV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.inf.0000214994.44346.d3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The Pediatric infectious disease journal\";s:9:\"\u0000*\u0000stitle\";s:23:\"Pediatr. infect. dis. j\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"426\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0891-3668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"DOERHOLT\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Katja\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"DUONG, Trinh\";i:1;s:13:\"GIBB, Diana M\";i:2;s:11:\"TOOKEY, Pat\";i:3;s:14:\"BUTLER, Karina\";i:4;s:15:\"LYALL, Hermione\";i:5;s:14:\"SHARLAND, Mike\";i:6;s:12:\"NOVELLI, Vas\";i:7;s:15:\"RIORDAN, Andrew\";i:8;s:11:\"DUNN, David\";i:9;s:15:\"SARAH WALKER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PIDJEV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.inf.0000214994.44346.d3\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.inf.0000214994.44346.d3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The Pediatric infectious disease journal\";s:9:\"\u0000*\u0000stitle\";s:23:\"Pediatr. infect. dis. j\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"426\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0891-3668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"DOERHOLT\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Katja\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"DUONG, Trinh\";i:1;s:13:\"GIBB, Diana M\";i:2;s:11:\"TOOKEY, Pat\";i:3;s:14:\"BUTLER, Karina\";i:4;s:15:\"LYALL, Hermione\";i:5;s:14:\"SHARLAND, Mike\";i:6;s:12:\"NOVELLI, Vas\";i:7;s:15:\"RIORDAN, Andrew\";i:8;s:11:\"DUNN, David\";i:9;s:15:\"SARAH WALKER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PIDJEV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.inf.0000214994.44346.d3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The Pediatric infectious disease journal\";s:9:\"\u0000*\u0000stitle\";s:23:\"Pediatr. infect. dis. j\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"426\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0891-3668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"DOERHOLT\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Katja\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"DUONG, Trinh\";i:1;s:13:\"GIBB, Diana M\";i:2;s:11:\"TOOKEY, Pat\";i:3;s:14:\"BUTLER, Karina\";i:4;s:15:\"LYALL, Hermione\";i:5;s:14:\"SHARLAND, Mike\";i:6;s:12:\"NOVELLI, Vas\";i:7;s:15:\"RIORDAN, Andrew\";i:8;s:11:\"DUNN, David\";i:9;s:15:\"SARAH WALKER, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PIDJEV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:153:\"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
